Mezclas y nanocompuestos de policaprolactona y resina fenoxi: caracterización, morfología y propiedades de transporte

La Tesis recoge un estudio experimental sobre mezclas y nanocompuestos de dos polímeros comerciales, ambos con peculiares capacidades a la hora de disgregar arcillas a nivel nanoscópico y de mezclarse con otros polímeros, lo que les hace particularmente atractivos a la hora de preparar masterbatches con altos contenidos en arcillas. Se han estudiado, entre otros efectos, el papel que las arcillas juegan en los fenómenos de cristalización de la policaprolactona y, sobre todo, en las propiedades de transporte de gases y vapores a través de los nanocompuestos obtenidos con las arcillas y los polímeros objeto de la Tesis. Con idénticos puntos de vista se han analizado mezclas binarias de ambos polímeros, incluyendo un estudio tentativo de uno de sus posibles nanocompuestos. Finalmente, se ha realizado un estudio de mezclas de policaprolactona con un polímero conductor, el polipirrol. En este caso, la cristalización del primero induce, con pequeñas cantidades del segundo, una red en éste que asegura una conductividad estimable y una mejora en las propiedades de transporte al dióxido de carbono.

Visual SLAM using straight lines

The present thesis is focuses on the problem of Simultaneous Localisation and Mapping (SLAM) using only visual data (VSLAM). This means to concurrently estimate the position of a moving camera and to create a consistent map of the environment. Since implementing a whole VSLAM system is out of the scope of a degree thesis, the main aim is to improve an existing visual SLAM system by complementing the commonly used point features with straight line primitives. This enables more accurate localization in environments with few feature points, like corridors. As a foundation for the project, ScaViSLAM by Strasdat et al. is used, which is a state-of-the-art real-time visual SLAM framework. Since it currently only supports Stereo and RGB-D systems, implementing a Monocular approach will be researched as well as an integration of it as a ROS package in order to deploy it on a mobile robot. For the experimental results, the Care-O-bot service robot developed by Fraunhofer IPA will be used.

Matemáticas, realidad y ciencia económica

Debido a la juventud de las ciencias económicas la discusión sobre la forma de utilizar las matemáticas en ellas permanece todavía abierta. En este artículo se tratara de responder a las cuestiones del "por qué" y, a la sin duda más actual, del "cómo" de la utilización de las matemáticas superiores en la economía.

Estudio de la trabeculectomía experimental mediante implante de PLGA como dispositivo de liberación controlada de fármacos

225 p. : il.

Contribution of Pannexin1 to Experimental Autoimmune Encephalomyelitis

Pannexin1 (Panx1) is a plasma membrane channel permeable to relatively large molecules, such as ATP. In the central nervous system (CNS) Panx1 is found in neurons and glia and in the immune system in macrophages and T-cells. We tested the hypothesis that Panx1-mediated ATP release contributes to expression of Experimental Autoimmune Encephalomyelitis (EAE), an animal model for multiple sclerosis, using wild-type (WT) and Panx1 knockout (KO) mice. Panx1 KO mice displayed a delayed onset of clinical signs of EAE and decreased mortality compared to WT mice, but developed as severe symptoms as the surviving WT mice. Spinal cord inflammatory lesions were also reduced in Panx1 KO EAE mice during acute disease. Additionally, pharmacologic inhibition of Panx1 channels with mefloquine (MFQ) reduced severity of acute and chronic EAE when administered before or after onset of clinical signs. ATP release and YoPro uptake were significantly increased in WT mice with EAE as compared to WT non-EAE and reduced in tissues of EAE Panx1 KO mice. Interestingly, we found that the P2X7 receptor was upregulated in the chronic phase of EAE in both WT and Panx1 KO spinal cords. Such increase in receptor expression is likely to counterbalance the decrease in ATP release recorded from Panx1 KO mice and thus contribute to the development of EAE symptoms in these mice. The present study shows that a Panx1 dependent mechanism (ATP release and/or inflammasome activation) contributes to disease progression, and that inhibition of Panx1 using pharmacology or gene disruption delays and attenuates clinical signs of EAE.